chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Loud ringing in ears; Mild sore arm; Neck tightness and ache on the left side connected to my arm.; Neck tightness and ache on the left side connected to my arm.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 05Apr2021 at 09:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included heartburn, high cholesterol and sulfonamide allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 21:00, the patient experienced loud ringing in ears, had not gone away. Noticed the first night and when the patient woke up the next day. It had been a week and they ring high pitch noise all day and night. Other non-concerning effects were mild sore arm and neck tightness and ache on the left side connected to the arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event loud ringing in ears, mild sore arm, neck tightness and ache on left side connected to the arm were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
pt recv vax 15MAY96 & 14OCT97 pt exp chickenpox;it was reported that pt had mild varicella w/8 to 10 lesions;
Initial information received on 22-Feb-2019 regarding an unsolicited valid non-serious case received from a other health care professional. This case involves a nine-years-old male patient who received a 0.5ml dose of vaccines DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] batch C5532AB, expiration date: 09-Oct-2020 via intramuscular route in the left deltoid on 18-Feb-2019. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant vaccinations included was HEPATITIS A VACCINE, PROQUAD and HEPATITIS B VACCINE. It was an actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration. A 9 year old male patient received QUADRACEL instead of TDaP and polio. It was unknown whether patient experienced any adverse event following vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
I went in for my yearly check up to have my blood checked on 06/14/2022. It came back showing I was severely anemic, very low on vitamin D3, low on B-12, very large red blood cells but low hemoglobin, my saturation is high. I went back on August 3, 2022 my blood showed I was still severely anemic, low on vitamin D3. I am very fatigued and do not have COVID-19, I test myself periodically using the home COVID-19 test. I will be getting a vitamin D2 50,000.
Patients vaccinated using old vial from 03/10/21; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients vaccinated using old vial from 03/10/21) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients vaccinated using old vial from 03/10/21). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients vaccinated using old vial from 03/10/21) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  Treatment medication was not provided   This case was linked to MOD-2021-208074, MOD-2021-258552, MOD-2021-258572, MOD-2021-258587, MOD-2021-258599, MOD-2021-258615, MOD-2021-258632, MOD-2021-258644, MOD-2021-258660, MOD-2021-258672, MOD-2021-258682, MOD-2021-258689, MOD-2021-258691, MOD-2021-258693, MOD-2021-258699, MOD-2021-258700, MOD-2021-258702, MOD-2021-258703, MOD-2021-258704, MOD-2021-258706, MOD-2021-207548, MOD-2021-258660 (Patient Link).
Headache, Sedation, Myalgia, Arthralgia,  NauseaVomiting, Swollen lymph nodes Narrative:
I had fever, body aches, sore throat for 5 day.  Developed pain in upper right stomach area and heart burn.   After 2 weeks I developed petechiae over the bicep of left arm and on both shins.  The heart burn and pain in stomach continued to get worse, and itching on the skin of the upper stomach had started.  On Aug 24, I woke with a sore throat at 1 AM.  I woke again at 6 AM with shin of my right leg hot, and a red spot 14mm in size. I had aches all over my body, and pain in my neck, under arms, in groin. It was extremely painful to stand.  I could not find medical help until Aug 25, 2021.  The spot on my leg had gotten bigger and painful.  I was diagnosed with Cellulitis.  I started a course of Bactrim DS .  On Day 10 of antibiotics 9/4/2021, i woke covered in a rash all over my body.  I could not get medical assistance.  I stopped antibiotics, started to take Benadryl for 5 days.  I was finally able to see my MD on 9/10.  The rash for the antibiotics finally disappeared on 9/15/21.  In the mean time, the petechiae, the stomach skin itching, and Cellulitus resolved.  I'm finally feeling better, 2 months later
Pt. was receiving multiple vaccines at the time of administration. Had not eaten breakfast. Immediately after receiving 2nd vaccination patient had an episode of syncope with loss of consciousness followed by convulsions that lasted approximately 30 seconds and followed by short term confusion. Reported feeling like she was in a cartoon. Pt. stayed in clinic for additional 15 minutes given apple juice, crackers, and chocolate afterwards and VS were stable before leaving clinic. LPN
Pt had suspected seizure. He had been taking his bottle, suddenly began shaking over all body including head, eyes rolled back into head. Episode lasted 30-45 seconds. He seemed dazed afterward, then cried and  slept. Exam was negative 15 min later. He was admitted for evaluation, discharge after 2 days with treatment
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (Pregnant) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1glass/week) on 16-Jun-2020. Concomitant products included METFORMIN for Polycystic ovarian syndrome, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, LEVOTHYROXINE SODIUM (UNITHROID) from 01-Jul-2020 to an unknown date for Thyroid disorder.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-May-2020 and the estimated date of delivery was 26-Feb-2021. On 21-Jun-2020, the patient experienced PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fifth week of the pregnancy.  At the time of the report, PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2020, Amniocentesis normal: normal. On 21-Jun-2020, Gestational diabetes: normal. On 21-Jun-2020, Glucose tolerance test: normal. On 21-Jun-2020, Pregnancy test: Positive. On 21-Jun-2020, Ultrasound scan normal: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
2 days in bed so far; Body aches; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (2 days in bed so far), PAIN (Body aches), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (2 days in bed so far), PAIN (Body aches), PYREXIA (fever) and CHILLS (chills). At the time of the report, BEDRIDDEN (2 days in bed so far), PAIN (Body aches), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided   Reporter did not allow further contact
approx 2 mins p/vax MMR onset of sz activity twitching face, head, skin pale, lips cyanotic; sz activity lasted approx 10 sec; BP 158/60, P64, R20, immed p/sz activity, PEARL, good ROM all extremities, alert, oriented; dizzy
Patient noted swelling of throat. Benadryl given as well as juice and crackers. patient noted improvement after 30 minutes. Mother was agreeable to take him home. Home precautions given.
The patient arrives to the clinic today for an Acute OV. She was last seen in the clinic on 1/19/2023 by FNP-C for Acute otitis externa of left ear. Medications given during the office visit included Ciprodex 0.3-0.1 % otic suspension and Claritin 10 MG tablet.   The patient arrived at the clinic with c/o of a swollen, erythematous, 8/10 throbbing pain to her left shoulder. "It fills like a pimple trying to come to a a head and burst."  She reports that her sxs started on Thursday night after receiving her Prevnar 20 vaccine in her left deltoid.  Reports being unable to raise her LUA d/t pain. Denies SOB, chest pain or inability to perform her ADLs.   VS stable in office @ 110/72, 88, 98%, 98.2   BMI: 40.06   Denies having any other issues or concerns at this time
Feeling "HOT", given crackers & water, began to experience weakness. began SOB. EPE was administered 0.3 ml X 1 dose.  Began shaking reported feeling better.  911 called to transport to hospital and patient notified that she can't  take the 2nd Covid dose, O2 was administered while waiting for EMS. 11:34AM arrived report given.
Headache, Arthralgia, Fever, chills, fatigue, sore throat Narrative
The patient has asthma. Thursday September 9 she thought she was having an asthma attack because she couldn't breathe and her chest was tight. She had no response to the rescue inhaler and she was taken to the hospital via ambulance to get steroids and was sent home. 24 hours later she fell to the floor and grabbed her chest and said she was having a heart attack. Her jaw was locked open and she couldn't speak. She was taken to the hospital via ambulance. Admitted to the hospital via ER. She was severely tachycardic and above 170. After 24 hours of having heart/breathing attacks in the hospital, she was transported to another hospital via ambulance due to her congenital heart defect. Upon arriving her attackes continued every 27-30 minutes. Her symptoms then attacked her limbs. Her right leg shot up in the air in a 90 degree angle and convulsed uncontrollably for 40 minutes. That happened for 24 hours. Her foot and hands would lock up in spasms. Throughout these five days in the hospital, she would become unconscience from 2 to 60 minutes.
Patient experienced a near syncopal episode with associated nausea. The nurse practitioner was notified and intervened. The patient was laid flat with her feet elevated until the episode passed. No LOC. She was monitored for 10 minutes with periodic blood pressure checks until stable discharge home.
Chronic sudden urticaria caused by a immune response to the Moderna booster. Hives started 1/24/22 and is still active (1/30/22) experiencing rash all over body and face with episodes of shortness of breath.
Mild muscle soreness at the injection site; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration, on an unspecified date, as dose number unknown, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date (after use of product), the patient was experiencing mild muscle soreness at the injection site. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Lt arm/shoulder redness, swelling post IM vaccines (DTaP & IPV) yesterday. No nausea, vomiting, fever. Tylenol prn was given.
Bruise at injection site, chills, shoulder pain, body aches, knee pain, headache, congestion feeling in head, tiredness, underarm tenderness and swelling in arm injected.  Treated with Tylenol 2x/day for 3 days
Initial report received on 20 November 2008 from a physician. A 45-year-old male patient, with no concurrent illnesses, and a history of heartburn, had received a first deltoid injection of FLUZONE SV 2008-2009 (lot number U27751AA, not a valid Sanofi Pasteur lot number) on 06 November 2008 at 16:00 pm. Approximately nine or 10 ten days (also reported as nine days) after receiving the FLUZONE, the patient experienced numbness around the right side of his mouth. Approximately two days later, the patient was evaluated by his physician and diagnosed with Bell's palsy. The patient was treated with Prednisone and Famciclovir. Blood work was drawn and a magnetic resonance imaging (MRI) of the brain was ordered; however the dates of service and results of both  tests were not provided. At the time of this report, the recovery status of the patient was "unknown." Documents held by sender: None
runs of Brady; B/P shooting through the roof.; Tachycardia; shortness of breath; wheezing; extreme weakness; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient reported for herself that she received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955) via an unspecified route in the left arm on 29Mar2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunization. Medical history included fibromyalgia. Allergies to medications, food, or other products included cefazolin (ANCEF), penicillin, and bandage tape. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included pregabalin (LYRICA) for fibromyalgia and BalanceMD (candida supplement). On 31Mar2021 at 09:00, the patient experienced runs of brady and tachycardia, shortness of breath, wheezing, extreme weakness, and blood pressure (B/P) shooting through the roof. These events resulted in emergency room/department or urgent care via squad hospital transport and were reported as non-serious. There was no treatment received for runs of brady and tachycardia, shortness of breath, wheezing, extreme weakness, and blood pressure (B/P) shooting through the roof. The clinical outcomes of runs of brady and tachycardia, shortness of breath, wheezing, extreme weakness, and blood pressure (B/P) shooting through the roof was recovering. Since the vaccination, the patient has not been tested for COVID-19.
3? x4? red rash at injection site Warm to touch Painful Chills and aches
On 6/29/17 pt was in to see FNP and received a MENVEO booster. On 6/30/17 she came in for a nursing visit appointment and C/O pain, redness, swelling and warm at the injection site. Medical Assistant informed me she was not given the complete vaccine, she was only given the liquid conjugate component. Pt was given the complete vaccine on 6/30/17 and office manager when in and spoke to the parents.
Pt reported R hand "coldness" and mild paleness starting after he received vaccine to R arm (1/20/23), still present on 1/23/23. Denies numbness, tingling, swelling, restriction of movement; weakness; radiation of sx.
05/01 Day after shot i ran 99.5 temp. Trouble sleeping.  Next morning (05/02) woke up with whiplash feel in left shoulder and neck, very tired. 9pm on (05/02) began running 100.5 temp and pain in left armpit and left side of neck and shoulder still hurting.  This morning (05/03) still have 99.3 temp, diarrhea  and left armpit,neck and shoulder still hurting.
I was given the FLu shot, tetanus and Shingles shot all in my right arm.  During the day I started to have pain in my arm. It was very difficult to bring arm up. Then slight headaches and pain in my eyes. Join and pain in my entire body accompany by chills and fever (100 degrees). It lasted 24 hours. Next morning after shot my arm was red and swollen and itchy. My arm is still  red and somewhat itchy on the side of the shots.
SLIGHT SIDE EFFECTS; This spontaneous report received from a consumer via a company representative via a social media concerned a female of unspecified age. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine  ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine  ad26.cov2.s. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2), the patient experienced slight side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of slight side effects was not reported. This report was non-serious. This case, from the same reporter is linked to 20211242345 and 20211242790.
Pt states she was vaccinated on 6/5/14. "Shortly after" she developed rash under bra line and abdomen. Rash looks like ant bites in clusters and are very itchy.
Painful arm where injection was received; worsened by next day and persisted until present time; mother notes pain has subsided but spasms still continue.
Client (DOB: 08/22/1987) received dose of COVID vaccine Janssen (lot #206A21A, exp 9/21/21) today at 0825. Client sitting in vaccination chair. Reported feeling ?lightheaded? at 0826. Skin dry and appropriate to Ethnicity. PHN offered client juice, and to lie down. Client stood up and lied down on the ground without assistance. At 0830 vitals taken: BP 140/90, HR 111 bpm, RR 20, SpO2 97%, client states ?feeling a lot better.? History of HTN, DM, Anxiety, smoker. Client reports a history of elevated pulse above 100 bpm. Client admits gets dizzy after receiving injections. Client had denied symptoms when asked prior to receiving vaccination. Client takes Risperdal, Amlodipine, Insulin, and Metoprolol. Client reports allergies to Amoxicillin with a rash onset one day after administration. PHN assisted client to sit up at 0833. Vitals: BP 113/96, HR 112 bpm, RR 16. Client denies feeling lightheaded, nausea, or s/s allergic reactions. At 0835 they assisted client to stand. Vitals? BP 128/88, HR 118 bpm, RR 16, SpO2 95%. Client states ?I feel good.? PHN educated to f/u with PMD today. At 0840 Client remained in observation area to finish 15-minute observation period. At 0845 client left walked off with steady gait, transport waiting to take back to program.
Malaise; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Malaise) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise) and PYREXIA (Fever). At the time of the report, MALAISE (Malaise) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No information on concomitant medication was provided.  No information on treatment medication was provided.
This spontaneous case was reported by a physician and describes the occurrence of THERAPEUTIC PRODUCT EFFECT DECREASED (Drug effect decreased) and PAIN (Pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis. Concurrent medical conditions included Psoriatic arthritis. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced THERAPEUTIC PRODUCT EFFECT DECREASED (Drug effect decreased) and PAIN (Pain). At the time of the report, THERAPEUTIC PRODUCT EFFECT DECREASED (Drug effect decreased) had not resolved and PAIN (Pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment information was not provided. This is not a valid case because there's no information about the date the patient took the vaccine and the start date of the adverse events. Therefore it is not possible to establish a causal relationship.; Sender's Comments: This is not a valid case because there's no information about the date the patient took the vaccine and the start date of the adverse events. Therefore it is not possible to establish a causal relationship.
I got nauseous and vomited a couple hours after the shot. Ever since then, I have bouts of not feeling well and nausea, sometimes vomiting.
Information has been received from a physician concerning a 25 year old female who was vaccinated with Varivax. Subsequently, seven days later the vaccination the patient developed a local reaction described as redness, blisters, itching and burning which lasted for a few days. unspecified medical attention was sought. the physician also report on other patients experience. (WAES0203USA02785). Additional information has been requested.